CRP and breast carcinoma: Findings for adiponectin, PAI‐1 and CRP in sensitivity analyses using cis‐SNP instruments for both overall and oestrogen receptor‐stratified breast cancer were consistent with those from the primary analysis (Supporting Information Table S4).